David Allison, Ph.D.

Managing Director
Westlake BioPartners

David Allision is the Managing Director at Westlake BioPartners with over 15 years of experience in healthcare investing, company formation, and translational research. Before joining Westlake, David was a Partner at 5AM Ventures in San Francisco and previously worked with the investment teams at Versant Ventures , Split Rock Partners, and PTV Healthcare Capital. Throughout his career

David has contributed to investments in companies that have developed important medicines, gone public, and been acquired. Notable companies such as AllRock Bio, Borealis Biosciences , CinCor Pharma (NASDAQ: CINC, acquired by AstraZeneca), Crinetics( NASDAQ: CRNX), Impel NeuroPharma(NASDAQ: IMPL), Inipharm , Magnetic Insight, Neurogastrx, Radionetics Oncology, and Recludix Pharma.

David holds a Ph.D. in Bioengineering from Rice University and a B.S.E. in Biomedical Engineering with honors from The University of Iowa.